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INTRODUCTION: Cystosarcoma phyllodes (CP) is a rare breast tumor occurring most often in females
in their ﬁfth decade. While usually benign, some CP tumors exhibit aggressive growth patterns and
extensively invade chest wall structures; resecting these tumors to negative surgical margins can be
challenging. We present a case of malignant CP involving the chest wall where using a negative pres-
sure vacuum-assisted closure (VAC) system after resection enabled complete histopathologic margin
assessment prior to reconstruction. This is the ﬁrst known report of staged breast tumor resection and
reconstruction with interim VAC coverage.
CASE PRESENTATION: A 48 year-old woman presented with rapidly increasing left breast size, fevers,
and fatigue. On examination, the left breast was massively enlarged with engorged vessels and skin
necrosis. Lab analyses revealed unusual metabolic abnormalities requiring preoperative hospitalization.
We performed a left modiﬁed radical mastectomy with partial resection of pectoralis major and minor
muscles, temporarily sealing thewoundwith a VACdue to concern for deeper tumor extension that could
require further resection. Pathology revealedmalignant CPwith a negative deepmargin. The 38 cmdefect
was then repaired with latissimus myocutaneous ﬂap plus skin graft. At three-year follow up the patient
remains free of disease.
CONCLUSION: In cases of malignant CP involving the chest wall, minimizing the extent of chest wall
resection is critical for reducing morbidity, while completely clearing tumor margins is essential for
reducing recurrence risk. Using temporary wound VAC coverage enables cautious debulking followed by
histopathologic margin assessment prior to deﬁnitively reconstructing the breast.
© 2014 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Cystosarcoma phyllodes (CP) represents less than 0.5% of all
breast neoplasms. It occurs almost exclusively in women and inci-
dence peaks in the 4th and 5th decades of life. Phyllodes tumors
oddly occurmore frequently in the left breast, and though the aver-
age size is quite large for a breast tumor – about 5 cm – lesions
exceeding 10 cm, termed “giant,” are common. Generally, tumors
are well demarcated, freely mobile, and are often discovered clini-
cally by patients. Both clinically and on imaging studies, the lesions
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appear similar to benign ﬁbroadenomas; biopsy is thus critical for
capturing the diagnosis [1,2].
Histopathologically, phyllodes tumors appear as diffuse cystic
spaces among overgrown stromal connective tissue. In general,
proliferation of stromal ﬁbroblasts characterizes benign lesions,
while cellular atypia and increasedmitoses characterizemalignant
lesions. Up to 90% of the tumors are histologically benign. How-
ever, in many cases, histopathologic appearance does not predict
tumor behavior. Furthermore, benign tumors that recur may do so
at a higher-grade.Malignant tumors can demonstrate sarcomatous
behavior and metastasize hematogenously to the lungs, skeleton,
heart, and liver. Because of these aggressive growth patterns, both
benign and malignant lesions should be excised completely with
no tissue left behind in order to prevent recurrence [3–5].
While studies have shown surgical margin status to be a prin-
cipal determinant of local recurrence and disease metastasis, there
are no ofﬁcial guidelines on how much to excise around lesions.
Many practitioners advocate for wide local excision with >1 cm
margins, citing higher recurrence rates with margins below this
[1,4–6]. In cases where disease extends to the chest wall, however,
http://dx.doi.org/10.1016/j.ijscr.2014.12.014
2210-2612/© 2014 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Fig. 1. Left breast mass, anterior view at presentation.
resecting to wide margins would violate chest wall integrity and
increase operative morbidity.
Wepresent a case ofmalignant CP so invasive thatwide excision
was impossible and tumor resection left a signiﬁcant possibility of
positive surgical margins. To address this possibility of reopera-
tion following the ﬁnal pathology report, we delayed chest wall
reconstruction and temporarily covered the surgical defect with
vacuum-assisted closure (VAC, Kinetic Concept Inc. – San Antonio,
TX, USA), a novel practice in breast surgery according to our review
of the literature.
2. Case presentation
A 48 year-old woman from the Philippines with no prior mam-
mographic screening was referred by her primary care physician
for a painful left breast mass that had rapidly enlarged over a ﬁve-
monthperiod. Thepatient originally noticed a small lump inher left
breast about 1 cm in diameter, which in several months’ time grew
to the sizeofwhat shedescribedas a “watermelon”. Thepatient also
reported a recent history of daily fevers to 39.4 ◦C, fatigue, dizziness
upon standing, and shortness of breath.
On physical examination, shewas tachycardic to 140 and febrile
to 38.9 ◦F. Her left breast was massively enlarged and tender, with
a ﬂattened nipple, engorged superﬁcial vessels, and deeply erythe-
matous, partially necrotic skin (Fig. 1).
Labs drawn at that time revealed widespread electrolyte and
hematologic disarray. Notably, hematocrit was low at 22.8, white
cell count elevated at 16,000, and platelets elevated at 690,000.
Liver function testswere abnormal and the patientwas both coagu-
lopathic andhemolytic. Iron studies suggestedconcomitant anemia
of chronic disease. The patient was immediately hospitalized for
electrolyte correction and multiple blood and plasma transfusions
prior to surgery.
Imaging of the left breast was limited due to its massive
size. Though mammography could not be performed, ultrasound
revealed an enormous heterogeneous mass underlying the left
breast and compressing the normal breast tissue anteriorly (Fig. 2).
A CT-chest scout image clearly showed the large extruding left
breast mass (Fig. 3), but abdominal and pelvic CTs showed no evi-
dence of distant disease. Incisional biopsy of the mass suggested a
malignant phyllodes tumor versus breast tissue sarcoma, and the
patient was scheduled for immediate surgery.
A left modiﬁed radical mastectomy (MRM) was performed in
which all gross disease was removed, including large regions of
the pectoralis major and minor muscles involved by tumor along
with the entire mass and breast. Tumor tissue was scraped off the
sternum and costochondral junction at ribs 3–5 and bone shav-
ings were taken for biopsy. After a 4h resection requiring 4 units
of packed red blood cells, 4.5 L of crystalloid, and 500 cc of albu-
Fig. 2. Transverse ultrasound, 3:00–12:00 axis, demonstrating a large hypoechoic
mass (arrows) that extends beyond the ﬁeld of view and compresses the normal
breast parenchyma seen superﬁcially.
Fig. 3. Scout image from CT of the chest demonstrates large left breast mass.
Fig. 4. VAC sponge covering left breast/chest wall defect measuring 38×28 cm.
min, intraoperative consultationwas heldwith plastic surgery. The
large soft tissue defect on the chest wall measured 38×28 cm and
exposed ribs and intercostalmuscles. Because of concern formicro-
scopic tumor extension through bone andmuscle requiring further
resection, it was decided that reconstruction be delayed until ﬁnal
margin statuswas known. Thedefectwas left open and temporarily
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Fig. 5. Left pathology slide shows an intra-canalicular (leaf-like) pattern of growth with periductal variable cellular stroma in CP (100X mag). Right slide shows a high-grade
sarcomatous component composed of spindle and giant cells and scattered mitoses (200X mag).
Fig. 6. Left latissimusmyocutaneous ﬂap/left thigh split-thickness skin graft recon-
struction of the left breast, 2 years after surgical reconstruction, anterior view.
sealed with a VAC sponge (Fig. 4). The excisedmass weighed 5.5 kg
and measured 26.2×23.9×15.4 cm.
The ﬁnal pathology of the mass was consistent with CP with
malignant features. Surgical margins were negative for tumor cells
but no margin exceeded 1mm; the smallest was the posterior at
0.3mm. Histopathologic viewing showed sheets of spindle cells
interspersed with malignant-appearing multinucleated giant cells,
cystic degeneration, and necrosis. There was a high nuclear grade
and a mitotic index of more than 20 mitoses per 10 HPF (Fig. 5).
Cytokeratin stainingaswell as ER, PR, andHER2-Neuwerenegative,
illustrating the complete stromal overgrowth and lack of epithe-
lial layers typical of sarcomatous tumors. Axillary lymph nodes
contained reactive lymphocytes only with no invading tumor cells.
TheMRMwas complicated by a left hydropneumothorax, found
incidentally on chest X-ray and attributed to the depth of resection
necessitated by tumor invasion. A chest tube was placed on the
open chest wound and removed after ﬁve dayswith full resolution.
Reconstruction of the breast and chest wall defect took place 1
week after the mastectomy with a left latissimus myocutaneous
ﬂap and left thigh split-thickness skin graft for additional skin
coverage (Fig. 6). A latissimus myocutaneous ﬂap was speciﬁcally
chosen inorder toprovide coverage for the soft tissuedefect andnot
for cosmetic reconstruction of the breast mound. It also served as
barrier protection for the chest wall since the patient was planned
for post-operative radiation. Reconstruction took 6h and there
were no complications.
As early as 1 week after surgery, the patient’s systemic symp-
toms and abnormal lab values began to trend down, with complete
resolution evident within the month. After hospital discharge, she
initiated a 6-month course of experimental valproate as histone
deacetylase inhibitor (HDACi) therapy, which has been postulated
to have both a cytotoxic and cell-differentiating effect (from high
grade to lowgrade tumor cells) onmyeloidmalignancies and tissue
sarcomas [7,8]. She also completed 6 weeks of external beam radi-
ation therapy. Three years after treatment, the patient continues to
do well with no evidence of disease recurrence.
3. Discussion
This report illustrates a unique case of CP, notable for its unusual
clinical presentation and therapeutic interventions.
Our patient’s malignant giant tumor grew rapidly, extended
through the chest wall, and caused widespread systemic symp-
toms and metabolic abnormalities. According to our review of the
literature, profound systemic effects are extremely rare in cases
of malignant CP. Based on the size of our patient’s tumor and its
histopathological appearance, the prognosis was guarded and the
disease managed aggressively.
We chose to perform a modiﬁed radical mastectomy with take-
downof all chestwall regions involvedoradjacent to tumor, leaving
the defect temporarily sealed with a wound VAC until the ﬁnal
pathology report determined that all margins were negative; only
thenwasdeﬁnitive reconstructive surgeryperformed. TheVAC sys-
tem involves applying a foam sponge to a wound space and adding
continuous controlled suction, which has been shown to drain
excess ﬂuid, increase blood ﬂow, and stimulate growth of gran-
ulation tissue [9]. VAC devices are commonly used at the bedside
to cover wounds that will ultimately self-appose; less commonly,
they are used in the primary coverage of surgical wounds.
Our review of the literature revealed cases of VACs used in gen-
eral surgery to temporize the coverage of surgical wounds after
colorectal abscess debridements, perforated bowel resections, and
scalpmalignancy excisions [10–12]. In plastic surgery, VACsmaybe
applied directly to tissue ﬂaps and skin grafts at the time of recon-
struction to add seal and enhance fusion [13]. In cases of breast
tumor resection and reconstruction, however, the use of tempo-
rizing VAC has not been reported to our knowledge, making this
treatment approach novel in our case.
Additional unusual treatment modalities used in this case were
adjuvant radiation and systemic chemotherapy. While there is
much debate over the use of radiation in CP, radiotherapy was
recommended for our patient since we could only attain just-
negative surgical margins [4–6]. Likewise, given the malignant
tumor’s potential for metastasis and its dramatic systemic impact
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prior to surgery, our patient underwent experimental HDACi med-
ical therapy thought to provide a cytotoxic and downgrading effect
on tumor cells left behind [7,8].
We propose that in cases of malignant CP extending to chest
wall, staging the resection and reconstruction with the aid of a
temporary closure device allows for deﬁnitive determination of
pathologic margins. If the margins on the chest wall are positive,
further chest wall resection can be performed at the time of recon-
struction.
4. Conclusion
In the surgical management of cystosarcoma phyllodes, 1 cm
tumor margins are usually attempted to prevent local recurrence;
however, a 1 cm margin is not always feasible on the deep (chest
wall)margin. In caseswhere the extent of disease precludes obtain-
ing wide margins without introducing increased morbidity, a goal
of complete tumor excision with negative margins may sufﬁce in
eliminating existing disease and preventing recurrence. Staging
tumor resection and reconstruction with temporary wound VAC
coverage allows for deﬁnitive assessment of margins in a situation
wheremargin clearance is essential forminimizing local recurrence
risk and chest wall resection carries signiﬁcant morbidity.
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